Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Meta-Analysis
. 2024 Sep;55(3):983-989.
doi: 10.1007/s12029-024-01055-1. Epub 2024 Apr 27.

Cachexia Index in Patients with Gastrointestinal Cancer: A Systematic Review and Meta-Analysis

Affiliations
Meta-Analysis

Cachexia Index in Patients with Gastrointestinal Cancer: A Systematic Review and Meta-Analysis

Yasuhiro Takano et al. J Gastrointest Cancer. 2024 Sep.

Abstract

Purpose: The cachexia index is a novel biomarker of cancer cachexia. This systematic review and meta-analysis aimed to evaluate the prognostic impact of cachexia index on prognosis after surgery for gastrointestinal cancer.

Methods: In August 2023, we systematically searched PubMed, the Cochrane Library, and Ovid for relevant studies on the oncological outcome after gastrointestinal cancer surgery and analyzed the findings from these studies for meta-analysis.

Results: Our systematic and meta-analysis review identified eight studies involving 1876 patients. The number of patients with low cachexia index accounted for 813 patients (43.3%). We found that low cachexia index was associated with worse overall survival (pooled HR, 2.30; 95% CI, 1.85-2.87; z = 7.49; P < 0.001) and disease/relapse/progression-free survival (pooled HR, 1.77; 95% CI, 1.45-2.18; z = 5.50; P < 0.001).

Conclusion: Our meta-analysis showed that cachexia index was associated with oncological outcome after gastrointestinal cancer surgery. However, the limitations of this meta-analysis should be taken into consideration when interpreting the results.

Keywords: Cachexia index; Gastrointestinal cancer; Meta-analysis; Survival.

PubMed Disclaimer

Similar articles

References

    1. Bray F, Ferlay J, Soerjomataram I, et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68:394–424. - DOI - PubMed
    1. Nellore J, Narayan AS, Sunkar S, et al. Circulating biomarkers for the early diagnosis of gastrointestinal cancers. Crit Rev Oncog. 2020;25:335–54. - DOI - PubMed
    1. Udomprasert A, Kangsamaksin T. DNA origami applications in cancer therapy. Cancer Sci. 2017;108:1535–43. - DOI - PubMed - PMC
    1. Bordry N, Astaras C, Ongaro M, et al. Recent advances in gastrointestinal cancers. World J Gastroenterol. 2021;27:4493–503. - DOI - PubMed - PMC
    1. Pullmer R, Linden W, Rnic K, et al. Measuring symptoms in gastrointestinal cancer: a systematic review of assessment instruments. Support Care Cancer. 2014;22:2941–55. - DOI - PubMed

MeSH terms